BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 31477272)

  • 1. Apolipoprotein C-II mimetic peptide is an efficient activator of lipoprotein lipase in human plasma as studied by a calorimetric approach.
    Reimund M; Wolska A; Risti R; Wilson S; Sviridov D; Remaley AT; Lookene A
    Biochem Biophys Res Commun; 2019 Oct; 519(1):67-72. PubMed ID: 31477272
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lipoprotein ApoC-II activation of lipoprotein lipase. Modulation by apolipoprotein A-IV.
    Goldberg IJ; Scheraldi CA; Yacoub LK; Saxena U; Bisgaier CL
    J Biol Chem; 1990 Mar; 265(8):4266-72. PubMed ID: 2307668
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel apolipoprotein C-II mimetic peptide that activates lipoprotein lipase and decreases serum triglycerides in apolipoprotein E-knockout mice.
    Amar MJ; Sakurai T; Sakurai-Ikuta A; Sviridov D; Freeman L; Ahsan L; Remaley AT
    J Pharmacol Exp Ther; 2015 Feb; 352(2):227-35. PubMed ID: 25395590
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A dual apolipoprotein C-II mimetic-apolipoprotein C-III antagonist peptide lowers plasma triglycerides.
    Wolska A; Lo L; Sviridov DO; Pourmousa M; Pryor M; Ghosh SS; Kakkar R; Davidson M; Wilson S; Pastor RW; Goldberg IJ; Basu D; Drake SK; Cougnoux A; Wu MJ; Neher SB; Freeman LA; Tang J; Amar M; Devalaraja M; Remaley AT
    Sci Transl Med; 2020 Jan; 12(528):. PubMed ID: 31996466
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human apolipoprotein A-II determines plasma triglycerides by regulating lipoprotein lipase activity and high-density lipoprotein proteome.
    Julve J; Escolà-Gil JC; Rotllan N; Fiévet C; Vallez E; de la Torre C; Ribas V; Sloan JH; Blanco-Vaca F
    Arterioscler Thromb Vasc Biol; 2010 Feb; 30(2):232-8. PubMed ID: 19910634
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reduction of plasma triglycerides in apolipoprotein C-II transgenic mice overexpressing lipoprotein lipase in muscle.
    Pulawa LK; Jensen DR; Coates A; Eckel RH
    J Lipid Res; 2007 Jan; 48(1):145-51. PubMed ID: 17018885
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Abnormal activation of lipoprotein lipase by non-equilibrating apoC-II: further evidence for the presence of non-equilibrating pools of apolipoproteins C-II and C-III in plasma lipoproteins.
    Tornoci L; Scheraldi CA; Li X; Ide H; Goldberg IJ; Le NA
    J Lipid Res; 1993 Oct; 34(10):1793-803. PubMed ID: 8245727
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lipoprotein lipase-catalyzed hydrolysis of phosphatidylcholine of guinea pig very low density lipoproteins and discoidal complexes of phospholipid and apolipoprotein: effect of apolipoprotein C-II on the catalytic mechanism.
    Shirai K; Fitzharris TJ; Shinomiya M; Muntz HG; Harmony JA; Jackson RL; Quinn DM
    J Lipid Res; 1983 Jun; 24(6):721-30. PubMed ID: 6688442
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lipoprotein lipase activity and interactions studied in human plasma by isothermal titration calorimetry.
    Reimund M; Kovrov O; Olivecrona G; Lookene A
    J Lipid Res; 2017 Jan; 58(1):279-288. PubMed ID: 27845686
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inverse association between apolipoprotein C-II and cardiovascular mortality: role of lipoprotein lipase activity modulation.
    Silbernagel G; Chen YQ; Rief M; Kleber ME; Hoffmann MM; Stojakovic T; Stang A; Sarzynski MA; Bouchard C; März W; Qian YW; Scharnagl H; Konrad RJ
    Eur Heart J; 2023 Jul; 44(25):2335-2345. PubMed ID: 37155355
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Apolipoprotein C-II: the re-emergence of a forgotten factor.
    Wolska A; Reimund M; Remaley AT
    Curr Opin Lipidol; 2020 Jun; 31(3):147-153. PubMed ID: 32332429
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of a lipoprotein lipase cofactor-binding site by chemical cross-linking and transfer of apolipoprotein C-II-responsive lipolysis from lipoprotein lipase to hepatic lipase.
    McIlhargey TL; Yang Y; Wong H; Hill JS
    J Biol Chem; 2003 Jun; 278(25):23027-35. PubMed ID: 12682050
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of plasma apolipoproteins on lipoprotein lipase-mediated lipolysis of small and large lipid emulsions.
    Yamamoto M; Morita SY; Kumon M; Kawabe M; Nishitsuji K; Saito H; Vertut-Doï A; Nakano M; Handa T
    Biochim Biophys Acta; 2003 Jun; 1632(1-3):31-9. PubMed ID: 12782148
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Pressure-dependent Model for the Regulation of Lipoprotein Lipase by Apolipoprotein C-II.
    Meyers NL; Larsson M; Olivecrona G; Small DM
    J Biol Chem; 2015 Jul; 290(29):18029-18044. PubMed ID: 26026161
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A review of the role of apolipoprotein C-II in lipoprotein metabolism and cardiovascular disease.
    Kei AA; Filippatos TD; Tsimihodimos V; Elisaf MS
    Metabolism; 2012 Jul; 61(7):906-21. PubMed ID: 22304839
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Apolipoprotein C-II: New findings related to genetics, biochemistry, and role in triglyceride metabolism.
    Wolska A; Dunbar RL; Freeman LA; Ueda M; Amar MJ; Sviridov DO; Remaley AT
    Atherosclerosis; 2017 Dec; 267():49-60. PubMed ID: 29100061
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aromatic residues in the C terminus of apolipoprotein C-III mediate lipid binding and LPL inhibition.
    Meyers NL; Larsson M; Vorrsjö E; Olivecrona G; Small DM
    J Lipid Res; 2017 May; 58(5):840-852. PubMed ID: 28159869
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Apolipoprotein C-II39-62 activates lipoprotein lipase by direct lipid-independent binding.
    MacPhee CE; Hatters DM; Sawyer WH; Howlett GJ
    Biochemistry; 2000 Mar; 39(12):3433-40. PubMed ID: 10727238
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modulation of lipoprotein lipase activity by apolipoproteins. Effect of apolipoprotein C-III.
    Wang CS; McConathy WJ; Kloer HU; Alaupovic P
    J Clin Invest; 1985 Feb; 75(2):384-90. PubMed ID: 3973011
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Post-heparin plasma lipoprotein and hepatic lipases. Relationships to high density lipoprotein cholesterol and to apolipoprotein CII in familial hyperalphalipoproteinemic and in normal subjects.
    Taskinen MR; Glueck CJ; Kashyap ML; Srivastava LS; Hynd BA; Perisutti G; Robinson K; Kinnunen PJ; Kuusi T
    Atherosclerosis; 1980 Oct; 37(2):247-56. PubMed ID: 7426098
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.